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Abstract
Obesity and related metabolic disorders have become leading causes of adult morbidity and mortality. KRAP (Ki-ras-induced
actin-interacting protein) is a cytoskeleton-associated protein and a ubiquitous protein among tissues, originally identified
as a cancer-related molecule, however, its physiological roles remain unknown. Here we demonstrate that KRAP-deficient
(KRAP
2/2) mice show enhanced metabolic rate, decreased adiposity, improved glucose tolerance, hypoinsulinemia and
hypoleptinemia. KRAP
2/2 mice are also protected against high-fat diet-induced obesity and insulin resistance despite of
hyperphagia. Notably, glucose uptake in the brown adipose tissue (BAT) in KRAP
2/2 mice is enhanced in an insulin-
independent manner, suggesting that BAT is involved in altered energy homeostasis in KRAP
2/2 mice, although UCP
(Uncoupling protein) expressions are not altered. Of interest is the down-regulation of fatty acid metabolism-related
molecules, including acetyl-CoA carboxylase (ACC)-1, ACC-2 and fatty acid synthase in the liver of KRAP
2/2 mice, which
could in part account for the metabolic phenotype in KRAP
2/2 mice. Thus, KRAP is a novel regulator in whole-body energy
homeostasis and may be a therapeutic target in obesity and related diseases.
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Introduction
Obesity and related metabolic disorders have become leading
causes of adult morbidity and mortality worldwide [1]. Obese
individuals have an increased risk of insulin resistance, progressing
to type 2 diabetes [2–4]. Increased adiposity develops when energy
intake exceeds energy expenditure [5]. Understanding the
regulatory circuits that govern energy, fat and glucose metabolism
has been a major focus of research interest, and genetic
manipulations of genes affecting these metabolisms revealed the
importance of systemic intertissue communication for the
underlying mechanisms [6–8].
KRAP, originally identified in a human colon cancer cell as a
deregulated gene, is strongly expressed in liver, pancreas and brown
adipose tissue (BAT) and rarely expressed in skeletal muscle or heart
in the adult mouse [9,10]. KRAP protein structure is highly
conserved between human and mouse species (80% homology) and
KRAP does not contain any known functional motifs predicted. No
apparent paralogous gene with KRAP is found in these species.
KRAP is immunohistologically localized along the bile canaliculi in
a fashionofco-existencewithfilamentous-actin inmouseliver and is
biochemically enriched in a cytoskeletal fraction, however, its
physiological role has not been elucidated [10].
Here we established and characterized KRAP
2/2 mice,
revealing that KRAP
2/2 mice displayed a profound metabolic
phenotype that exhibits increased metabolic rate, reduced
adiposity, improved glucose tolerance, hypoinsulinemia and
hypoleptinemia. More importantly, KRAP
2/2 mice are protected
against diet-induced weight gain, fatty liver formation and insulin
resistance under a high-fat diet, implicating KRAP as a potential
target in therapy for obesity and related diseases.
Results
KRAP
2/2 mice show altered energy homeostasis and
decreased adiposity
To examine the physiological role of KRAP, KRAP
2/2 mice were
generated with deletion of 55% of the coding region of KRAP
(Figure 1A). Homologous recombination was confirmed by Southern
blotting (Figure 1B) and KRAP protein wasnot detected in KRAP
2/2-
liver (Figure 1C). Genotype analysis of offspring from heterozygous
matings was consistent with Mendelian inheritance (data not shown),
suggesting that KRAP is dispensable in embryonic development. All
the KRAP
2/2 mice in the mixed genetic background of 129SV/J and
C57BL6/J were fertile and appeared to have a normal life span,
however, KRAP
2/2 mice displayed a remarkable reduction in weight
gain after birth (Figure S1). To further elucidate the physiological/
pathological phenotypes, KRAP
2/2 mice with the genetic back-
ground of C57BL6/J were established and extensively analyzed.
Total body weight (BW) at birth was not different between
KRAP
2/2 and wild-type mice (Table S1). KRAP
2/2 offspring
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total BW was observed in KRAP
2/2 mice relative to wild-type
littermates throughout life (Figure 1D). Although KRAP
2/2 mice
displayed a significant increase in food intake (per BW
0.75)
(Figure 1E), their epididymal white adipose tissue (WAT) mass
per BW was less than that of wild-type mice (Figure 1F). BAT mass
in the KRAP
2/2 mice tended to be lower compared with wild-type
mice, although the difference was not statistically significant
(Figure 1F). Triglycerides in liver of KRAP
2/2 were less than those
in the wild-type controls (Figure 1G). In contrast, neither muscle
triglyceride contents nor liver glycogen contents were different
between the genotypes (Figure 1G, Table S1).
The possibility that KRAP
2/2 mice show lean phenotype due to
the result of poor nutrient absorption was examined. The ash
weight ratio to food intake and the total amount of proteins in the
feces were comparable between the genotypes (Figure 1H, Table
S1). Furthermore, one-hour (h) postprandial blood glucose levels
after overnight fasting were comparable between the genotypes
(data not shown). These results show that malabsorption does not
occur in the KRAP
2/2 mice.
Histological analysis of epididymal WAT and BAT showed a
remarkable reduction in cell size (Figure S2), possibly due to the
lower content of triglycerides in KRAP
2/2 mice. Furthermore, a
reduction in the subcutaneous fat content of KRAP
2/2 mice was
observed compared with that of wild-type mice (Figure S2). Liver
and skeletal muscle of KRAP
2/2 mice had no obvious histological
abnormality (Figure S2).
The phenotype of decreased weight gain despite normal food
intake and absorption in KRAP
2/2 mice suggests that there must
be an increase in whole-body energy expenditure. To explore this
possibility, the metabolic rate was examined by indirect calorim-
etry, revealing that KRAP
2/2 mice showed an enhanced metabolic
rate both in the daytime and at night (Figure 2A). Metabolic fuel
source analyzed by respiratory quotient was comparable between
the genotypes (Table S1). To characterize the mechanisms
underlying higher metabolic rate in KRAP
2/2 mice, locomotor
activity and rectal temperature were examined. KRAP
2/2 mice
showed a slight increase in locomotor activity, which was more
evident in the dark than in the light periods (Figure 2B). The slight
increase in the locomotion of KRAP
2/2 mice seemed to reflect
increased exploration for food, but the increase in locomotor
activity partially account for the higher energy expenditure in
KRAP
2/2 mice. On the other hand, rectal temperatures on fed or
fasted conditions and UCP1 expression were not different between
Figure 1. KRAP2/2 Mice Showed Decreased Weight-Gain and Decreased Adiposity. (A) Targeted disruption of the KRAP gene. A region of
the murine KRAP gene containing exons 11–16 was replaced with a neomycin resistance cassette. DT-A, Diphtheria-toxin A fragment; E, exon; neo,
pGKneo. (B) Southern blotting of EcoRV digested tail DNA using the 59 external probe A. WT, wild-type; HT, heterozygous; KO, KRAP2/2. (C) Western
blotting with the KRAP antibody of liver lysates. (D) Body weight (BW) for KO and WT mice (n=5–14 per group). P,0.01; F (1, 8)=160.3 for male;
P,0.01; F (1, 11)=146.4 for female. (E) Food intake for KO and WT mice normalized by BW0.75. 30–36 weeks of age; n=6. P,0.01; F (1, 10)=12.6. (F)
Percent body fat mass of epididymal white adipose tissue (WAT) and interscapular brown adipose tissue (BAT) (20 weeks of age; n=9). (G) Tissue
triglyceride content of livers and skeletal muscles, n=9. (H) Daily ash mass of adult mice normalized to their food intake, n=10. All the data are
presented as mean6S.E.M.; *P,0.05; **P,0.01 compared with wild-type controls.
doi:10.1371/journal.pone.0004240.g001
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response of the KRAP
2/2 mice to cold environment is not
defective (data not shown), suggesting that thermogenesis may not
account for the enhanced energy expenditure in KRAP
2/2 mice,
although the possibility of enhanced heat radiation from the body
surface of KRAP
2/2 mice has not been excluded.
Protection against diet-induced obesity and insulin
resistance in KRAP
2/2 mice
Next, we asked whether these mice are protected against
increased adiposity induced by a high-fat diet (HFD). When fed an
HFD for 4 weeks, KRAP
2/2 and wild-type mice gained about 30%
and 50% in BW, respectively (Figure 3A), although KRAP
2/2
mice displayed a significant increase in food intake (Figure 3B).
The metabolic rate for KRAP
2/2 mice on an HFD was higher in
comparison to wild-type levels (Figure 3C), whereas the respiratory
quotient in KRAP
2/2 mice under HFD was comparable with that
in the wild-type (Table S1). Epididymal WAT mass, BAT mass
and tissue triglyceride contents in the liver and muscle were
obviously decreased in KRAP
2/2 mice relative to the wild-type
mice (Figure 3D, Table S1). Furthermore, KRAP
2/2 mice showed
resistance to the formation of fatty liver (Figure 3E, 3F). These
results together indicated that KRAP
2/2 mice do not become
obese on an HFD.
We then asked whether KRAP
2/2 mice maintain insulin
sensitivity on an HFD. Blood glucose levels tended to be lower
in the KRAP
2/2 mice and basal insulin levels for KRAP
2/2 mice
were lower than those for wild-type mice (Table S1). KRAP
2/2
mice also displayed excellent glucose tolerance and peripheral
insulin action during HFD feeding (Figure 3G, 3H). All these
results together suggested that KRAP
2/2 mice are protected
against diet-induced obesity and insulin resistance.
Serum glucose, insulin, leptin and triglycerides were
lower in KRAP
2/2 mice
To more precisely understand the physiology of KRAP
2/2 mice,
their serum chemistries were examined. Serum cholesterol, free
fatty acid (FFA), ketone body, glucagon and albumin were
indistinguishable between KRAP
2/2 and wild-type mice, whereas
serum glucose, insulin, leptin and triglycerides were lower in
KRAP
2/2 mice (Table S2). Adipokines such as leptin and
adiponectin are thought to play an important role in the regulation
of energy homeostasis and in glucose and fatty acid metabolism
[11–14]. Serum leptin levels for KRAP
2/2 mice under HFD were
also significantly lower than those of wild-type mice (Table S1).
The hypoleptinemia can explain the hyperphagia, but not the
enhanced energy expenditure in KRAP
2/2 mice [11–13]. On the
other hand, serum adiponectin was higher in KRAP
2/2 mice
under standard diet (Table S2), however, there was no difference
under HFD between the genotypes (Table S1), suggesting that
adiponectin may not be directly involved in the phenotype
observed in KRAP
2/2 mice. There was no increase in thyroid
hormones, T3 (triiodothyronine) or T4 (thyroxine), associated with
an increase in metabolic rate. Growth hormone and IGF-1,
implicated in maintaining body composition [15–17], were not
significantly altered. These results together suggested that other
factors and/or mechanisms will be involved in energy expenditure
in KRAP
2/2 mice.
ACC-1, ACC-2 and FAS were reduced in the KRAP
2/2-liver
To understand molecular events in KRAP
2/2 mice, the
expressions of mRNA involved in fatty acid metabolism, including
Acetyl-CoA carboxylase (Acc), Acyl-CoA oxidase 1 (Acox1), lipoprotein lipase
(Lpl), hormone sensitive lipase (Hsl), peroxisome proliferators activated receptor
gamma (Pparg), Pparg coactivator 1 alpha (Pgc1a), uncoupling protein (Ucp),
adipocyte fatty acid binding protein4 (Fabp4) and Leptin, were examined
in liver, skeletal muscle, WAT and BAT. Among these genes, Acc2
is a critical regulator for the balance between synthesis and
oxidation of fatty acid [18]. Acc2-deficient mice have a metabolic
phenotype that exhibits increased metabolic rate and decreased
adiposity [19], which is similar to that observed in KRAP
2/2 mice.
Interestingly, KRAP
2/2 mice showed reduced expressions of Acc1
and Acc2 in the liver compared with the wild-type mice (Figure 4A),
whereas the expression levels of Acc2 in skeletal muscle and BAT
did not differ between the genotypes (Figure 4B, 4D). Ucp is known
to be involved in the regulation of thermogenesis and energy
expenditure through the sympathetic nervous system [20], and
Acox1 catalyzes fatty acid oxidation. KRAP-deletion had no effect
on the expressions of Ucp and Acox1 in the tissues examined (Ucp1
for BAT, Figure 4D; Figure S3; Ucp2 for liver and WAT, Figure 4A
and 4C; UCP-3 for skeletal muscle, Figure S4), which was
consistent with no difference in rectal temperature measurements
(Figure 2C). In WAT and BAT, the expressions of genes involved
in fatty acid uptake, trapping and lipolysis, such as Lpl, Fabp4, Hsl
and Pparg were not changed in KRAP
2/2 mice. Neither Leptin
expression in WAT nor Pgc1a expression in BAT was different
between the genotypes. All these results suggest that fatty acid
synthesis is attenuated especially in the liver of KRAP
2/2 mice,
where glucose oxidation and/or fatty acid oxidation might be
Figure 2. Enhanced Energy Expenditure in KRAP2/2 Mice. (A) Whole-body energy expenditure measured by indirect calorimetry (22 weeks of
age). 6,4066339 and 5,2916331 kJ/day/kg BW0.75), KRAP2/2 (KO) and wild-type (WT) mice, respectively. P,0.05; F (1, 13)=4.8; n=7–8 per group.
(B) Spontaneous ambulatory activity of mice evaluated for 24 h. Total ambulatory activity per day was 12,07661,351 and 7,71661,100 counts/day,
KO and WT, respectively. P,0.05; F (1, 10)=6.3; n=6. (C) Rectal temperature in the fed or overnight-fasted conditions (n=7–8). All the data are
presented as mean6S.E.M.; *P,0.05; **P,0.01 compared with wild-type controls.
doi:10.1371/journal.pone.0004240.g002
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synthase (FAS) proteins were decreased by precisely 67%, 42%
and 25% respectively in KRAP
2/2-liver (Figure 4E), which is
consistent with the reduced mRNA levels and liver triglyceride
content in KRAP
2/2 mice (Figure 4A, 1G).
To examine whether KRAP autonomously affects the expres-
sions of lipogenic enzymes in cells, RNA interference-mediated
suppression of KRAP in HepG2 cells was performed. No change
in the levels of lipogenic genes was observed in the cells (Figure 4F),
suggesting that KRAP may not autonomously regulate lipogenic
gene expression in the cells. However, the possibility of the KRAP-
autonomous effects in lipogenic gene expression is not excluded
due to the incomplete knockdown of KRAP in this experiment.
From the viewpoint of ACC regulation, adiponectin is
intriguing in that it phosphorylates and activates 59-AMP-
activated protein kinase (AMPK) [21], resulting in the phosphor-
ylation and inactivation of ACC. However, the phosphorylation
statuses of ACC-1, ACC-2 and AMPK were not different between
the genotypes (Figure 4E), suggesting that the adiponectin-AMPK
pathway is unlikely to contribute to the decreased expressions of
the lipogenic genes in KRAP
2/2-liver. These results suggested that,
although the precise pathway causing the attenuation of lipogenic
enzymes in KRAP
2/2-liver remains unclear, the decrease in fatty
acid synthesis-related genes including Acc2 in KRAP
2/2-liver
might function as a critical mediator of the altered energy
homeostasis in KRAP
2/2 mice.
Improved glucose tolerance and increased insulin-




2/2 mice show a significant reduction in circulating
insulin levels with lower glucose levels (Table S2), a glucose
tolerance test was performed. KRAP
2/2 mice displayed improved
glucose tolerance with lower insulin levels compared with wild-
type mice (Figure 5A, 5B), suggesting the possibility that peripheral
insulin sensitivity and/or insulin-independent glucose uptake is
enhanced in KRAP
2/2 mice.
Subsequently, an insulin sensitivity test was performed. The rate
of glucose clearance upon insulin injection was slightly higher in
KRAP
2/2 than in wild-type mice, suggesting that whole-body
insulin sensitivity appears to be enhanced in the absence of KRAP
(Figure 5C).
Next, to examine whether insulin-independent glucose uptake
differs between the genotypes, the clearance of
18F-fluorodeoxyglu-
cose (
18F-FDG) was analyzed under an overnight-fasted condition
by animal PET (positron emission tomography). PET imaging
revealed the enhanced glucose uptake in BAT of KRAP
2/2 mice
relative to wild-type mice (Figure 5D, 5E). Quantification of total
glucose uptake into various tissues indicated the 2-fold higher
uptake in KRAP
2/2-BAT compared with wild-type control
(Figure 5F), whereas KRAP
2/2-BAT showed hypotrophic appear-
ance (Figure 1F, S2, 3D). Besides BAT, there was no tissue showing
higher glucose uptake in KRAP
2/2 mice relative to wild-type mice
Figure 3. Protection Against Diet-Induced Obesity and Insulin Resistance in KRAP2/2 Mice. (A) BW-gain under high-fat diet (HFD) for
KRAP2/2 (KO) and wild-type (WT) mice. n=6–7; P,0.02; F (1, 11)=9.5. (B) Food intake under HFD for KO and WT mice normalized by BW0.75. n=6–
7; P,0.05; F (1, 11)=5.0. (C) Whole-body energy expenditure measured by indirect calorimetry after 4 weeks of an HFD. 4,6946598 and
3,3896496 kJ/day/kg BW0.75, KO and WT, respectively. n=5–6; P,0.05; F (1, 9)=5.9. (D) Percent body fat mass of epididymal white adipose (WAT)
after 4 weeks of an HFD (left panel) or brown adipose tissue (BAT) after 18 weeks of an HFD (right panel). n=6–7. (E) Gross appearance of liver from
KO and WT mice after 14 weeks of an HFD. (F) Histological analysis of the livers represented in (E) performed by Oil Red-O and hematoxylin staining.
Scale bar, 100 mm. (G) Blood glucose concentrations before and 120 min after the single glucose i.p. injection at a dose of 2 g glucose/kg BW.
Glucose tolerance test performed after 8 weeks of an HFD (n=7–8 per group). (H) Insulin sensitivity test performed after 8 weeks of an HFD. n=7–8;
P,0.01; F (1, 13)=9.9. All the data are presented as mean6S.E.M.; *P,0.05; **P,0.01; #P,0.001 compared with wild-type controls.
doi:10.1371/journal.pone.0004240.g003
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plays a significant role in improved glucose tolerance and altered
energy homeostasis in KRAP
2/2 mice. As the
18F-FDG dose used in
the analysis had no effect on pancreatic insulin secretion, the higher
glucose uptake in BAT of KRAP
2/2 mice is insulin-independent.
Indeed, phosphorylation of Akt and insulin receptor were not
enhanced in KRAP
2/2-BAT (Figure S5A, S5B), indicating that
proximal insulin signaling is not involved in the higher glucose
uptake in KRAP
2/2 mice and that the difference in insulin
sensitivity may be a result due to relative higher insulin-independent
glucose uptake in KRAP
2/2-BAT.
To examine whether the enhanced glucose uptake is autono-
mously caused by BAT cells, primary adipocytes from BAT were
prepared. These showed that there was no significant difference in
glucose uptake in the presence or absence of insulin between the
genotypes (Figure 6A). Furthermore, KRAP-deletion in the
cultured preadipocytes had no obvious effect on the differentiation
process into adipocytes in histology and particular protein
expressions (Figure 6B, 6C). Insulin-dependent Akt activation
was examined, showing that the levels of phosphorylated Akt
protein were comparable between the genotypes (Figure 6D). All
these results suggested that not only cell autonomous effects of
KRAP but also particular extracellular factors would be necessary
for the improved glucose tolerance in KRAP
2/2-BAT and that
KRAP in adipocytes would have a critical function in glucose
uptake besides directly regulating insulin signaling.
Discussion
KRAP
2/2 mice display a profound metabolic phenotype that
exhibits higher basal metabolic rate, resulting in decreased
adiposity concomitant with improved glucose tolerance, hypoin-
sulinemia and hypoleptinemia. KRAP
2/2 mice are protected
against diet-induced obesity and insulin resistance under HFD.
Tissue-specific insulin-independent glucose uptake in BAT will be
involved in the metabolic phenotype in KRAP
2/2 mice.
Some of the KRAP
2/2 offspring in the C57BL6/J genetic
background died during the nursing period, but not in the mixed
genetic background of 129SV/J and C57BL6/J. The KRAP
2/2
offspring in the C57BL6/J genetic background exhibited a normal
life span after weaning. The KRAP heterozygous mice do not
exhibit the metabolic phenotype as far as we examined (data not
shown), suggesting that sufficient reduction of KRAP expression
beyond the particular threshold may be necessary for the
manifestation in the whole-body metabolism. Taken together,
abolition of KRAP does not severely influence adult life and KRAP
could become a molecular target for lifestyle-related diseases.
The reduced fat deposits in KRAP
2/2 mice can be explained by
the increased whole-body energy expenditure. As increased
physical activity in KRAP
2/2 mice is restricted to dark period
(Figure 2B), the higher physical activity does not fully account for
the increased whole-body energy expenditure, suggesting that
other processes such as heat production will be involved in the
altered energy homeostasis in KRAP
2/2 mice. Although differ-
ences in rectal temperature and UCP-1 expression between the
genotypes were not observed (Figure 2C, 4D, S3), the possibility of
participation of heat radiation from the body surface of KRAP
2/2
mice in the higher metabolic rate is still not excluded. Another
possibility is that fuel is consumed in other than heat production or
fat storage in BAT [22,23], because PET imaging confirmed that
BAT is involved in the enhanced glucose uptake in KRAP
2/2 mice
(Figure 5D–F).
Of note is the improved glucose tolerance in KRAP
2/2 mice. In
general, leanness reveals increased insulin sensitivity and this will
be a plausible idea applied for KRAP
2/2 mice (Figure 3H, 5C).
Indeed, KRAP does not affect directly insulin signaling process as
far as we examined (Figure 6D). On the other hand, our
observation that KRAP
2/2-BAT predominantly uptake glucose
in an insulin independent manner is interesting, and this finding
will lead to new concepts for improved glucose metabolism.
GLUT-1 is a candidate molecule involved in insulin-independent
glucose uptake [24]. GLUT-1 expression levels in BAT are not
Figure 4. Reduced Expressions of ACC-1, ACC-2 and FAS in KRAP2/2-Liver. Northern blot analysis in liver (A), skeletal muscle (B), white
adipose tissue (WAT; C) and brown adipose tissue (BAT; D) isolated from KRAP2/2 (KO) and wild-type (WT) mice. (E) Western blot analysis of total-,
phospho-ACC (P-ACC) and FAS of liver isolated from KO and WT mice (left). Densitometric quantification of ACC-1, ACC-2 and FAS normalized by
actin content (right; n=6; *P,0.001). Data are presented as mean6S.E.M. (F) Western blot analysis of ACC and FAS expressions in HepG2 cells 72 h
after the transfection of siRNAs. Scramble-siRNAs were used as controls.
doi:10.1371/journal.pone.0004240.g004
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qualitative changes in GLUT-1 or the other transporters may
contribute to the altered glucose uptake in KRAP
2/2-BAT.
Elucidation of the molecular mechanisms beneath the insulin-
independent glucose uptake in KRAP
2/2 mice may lead to the
development of medicines for patients suffering from insulin
resistance.
Recently, the importance of identification of networks rather
than one or two genes has been reported to understand the
molecular pathology of the diseases [25,26]. Although incomplete
KRAP knockdown should be considered in the HepG2-experi-
ment, systemic intertissue communication might be involved in the
metabolic phenotype of KRAP
2/2 mice, based on the finding that
both the in vitro culture system of HepG2 and differentiated
adipocytes do not reproduce phenomena observed in KRAP
2/2
mice in vivo (Figure 4F, 6A).
To discuss hypothetical molecular pathology underlying the
metabolic phenotype of KRAP
2/2 mice, microarray gene
expression analyses on BAT and liver were performed (Data were
deposited in NCBI Gene Expression Omnibus. Accession number;
GSE13585). To extract differentially expressed genes between the
KRAP
2/2- and wild-type-tissues, Venn diagrams with 1.5-fold
change in the three pairs comparisons was used as the filtering
method, revealing that 272 probesets in BAT and 422 probesets in
liver were changed in the three pairs of comparisons. Out of the
272 probesets, 114 and 158 were up- and down-regulated in
KRAP
2/2-BAT, respectively (Figure S6). Out of the 422 probesets,
199 and 223 were up- and down-regulated in KRAP
2/2-liver,
respectively (Figure S6). The down-regulated genes in KRAP
2/2-
BAT were strongly associated with Gene Ontology (GO) terms
such as ‘‘fatty acid biosynthesis’’ and ‘‘fatty acid metabolism’’
(Table S3), which is comparable with the appearance of a
decreased adiposity in KRAP
2/2-BAT (Figure S2). Fatty acid
desaturases such as Scd1, Fads3 and Sc5d were found as the down-
regulated genes in KRAP
2/2-BAT (Table S3). Among them, Scd1
is remarkable from the viewpoint that Scd1-deficient mice show an
increase in metabolic rate and a decrease in adiposity [27,28], and
Scd1 might function as a critical mediator of the altered energy
homeostasis in KRAP
2/2 mice.
Intriguing is that Dio2, which catalyzes the extrathyroidal
production of the active thyroid hormone T3 via deiodination of
T4 [22], is detected as one of the up-regulated genes in KRAP
2/2-
BAT (Table S3). Although well-known critical regulators of energy
homeostasis such as Acox, Ppargc1a (also known as Pgc1a) and Ucp1
Figure 5. Improved Glucose Tolerance and Increased Insulin-Independent Glucose Uptake into KRAP2/2 Brown Adipose Tissue. (A)
Intraperitoneal glucose tolerance test in age-matched pair (15–17 weeks of age) of male mice on a standard diet. n=10; P,0.01; F (1, 18)=12.1. (B)
Serum insulin concentrations before and 10 min after the single glucose i.p. injection at a dose of 2 g glucose/kg BW. Age-matched pair (9–11 weeks
of age) of male mice. n=8–10; P,0.01; F (1, 15)=10.8. (C) Insulin sensitivity test in age-matched pair (21–27 weeks of age) of female mice on a
standard diet. n=14–15; P=0.07; F (1, 27)=3.5. (D) PET image showing the enhanced accumulation of 18F-FDG in the brown adipose tissue (BAT) of
KRAP2/2 (KO) mice. Arrow indicates a location of the BAT. A separate experiment in the same procedure was performed on five pairs of mice and
the similar results were obtained. Gradation bar indicates signal intensity. (E) Time-activity curves of 18F-FDG in BAT (red circle), brain (dark blue
circle), liver (green circle), kidney (pale blue circle) and muscle (brown circle) were obtained from the mean pixel radioactivity in ROI of the images
shown in (D) (n=5). (F) Quantification of the 18F-FDG uptakes in blood, brain, heart, muscle (Musc), liver, kidney (Kid), pancreas (Panc), BAT,
epididymal white adipose tissue (WAT) and bladder (Blad) after the PET imaging (n=5). All the data are presented as mean6S.E.M.; *P,0.05;
**P,0.01 compared with wild-type controls.
doi:10.1371/journal.pone.0004240.g005
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hormone level is low in KRAP
2/2 mice (Table S2), suggesting that
the altered Dio2 expression might be a molecular basis underlying
the metabolic phenotype of the KRAP
2/2 mice. At this view point,
the report that bile acids from liver affect the deiodinase activity in
BAT [29] is fascinated, because KRAP protein localizes beneath
the bile canalicular membrane of hepatocytes [10].
In KRAP
2/2-liver, the down-regulated genes were strongly
associated with GO terms such as ‘‘cholesterol biosynthesis’’ and
‘‘lipid biosynthesis’’ (Table S4), which is consistent with the lower
triglyceride contents in KRAP
2/2-liver (Figure 1G). Although some
well-investigated lipogenic transcription factors including Srebf1
were not altered, many critical regulators in lipid metabolism such
as Scd1, Acacb (also known as Acc2), Fasn (also known as Fas), Fabp5,
Ppard, Acss2, Hmgcs1, Cyp51 and Sc5d were found as the down-
regulated genes (Table S4, Figure 4A, 4E), suggesting the
complexity of the molecular pathology of the KRAP
2/2 mice.
Among the down-regulated genes, Acc2 and Scd1 are especially
interesting, because both Acc2-deficient mice and Scd1-deficient
mice show increased energy expenditure and decreased adiposity
[19,27,28]. Considering the enhanced glucose uptake in KRAP
2/2-
BAT, the down-regulation of fatty acid metabolism-related genes in
KRAP
2/2-liver may result from the relatively lower glucose uptake
into KRAP
2/2-liver (Figure 5E, 5F), however, the decrease in fatty
acid metabolism-related genesincludingAcc2andScd1inKRAP
2/2-
liver might function as a critical mediator of the altered energy
homeostasis in KRAP
2/2 mice.
Of interest is up-regulation of Lepr and Acaa1a (also known as
PTL) in the KRAP
2/2-liver (Table S4), suggesting the presence of
enhanced leptin sensitivity and its contribution to the metabolic
phenotype of KRAP
2/2 mice [11–14]. In association with this
observation, the discrepancy observed in KRAP
2/2 mice between
decreased circulating serum leptin (Table S2) and normal WAT
leptin mRNA levels (Figure 4) might suggest the existence of
dysregulation of leptin production from WAT and/or increased
peripheral leptin sensitivity in KRAP
2/2 mice. Based on the recent
reports showing that insulin increases leptin translation [30,31],
hypoinsulinemia may affect the leptin turnover, which might
contribute in part to the metabolic phenotypes in the KRAP
2/2
mice. As Acaa1a is suspected to be involved in fatty acyl-CoA b-
oxidation pathway [32], assessment of the relevant pathways to the
KRAP
2/2-liver metabolism should be a subject of future studies,
although the expression level of Acox is not changed in the KRAP
2/2-
liver (Figure 4A).
Although critical genes for the regulationof fatty acid metabolism
and/or energy metabolism such as Scd1, Acc2, Dio2 and Lepr were
differentially expressed in KRAP
2/2-BAT or liver, other multiple
KRAP-regulated pathways and the interplays of these in vivo should
be considered for potential mechanisms underlying the metabolic
phenotypes in KRAP
2/2 mice. The smaller size of adipocytes in
WAT and BAT may be one of the possible mechanisms protecting
from lipotoxic effects of spilled fat to other tissues, which could also
explain the improved glucose tolerance in the KRAP
2/2 mice.
Another possibility of the participation of sympathetic nervous
system is not excluded in the pathogenesis of KRAP
2/2 mice,
although normal UCP1 levels and lower Adrb3 levels existed in the
KRAP
2/2 mice (Figure 4D, S3 and Table S3). Thus, the
determinationof the precise mechanismof themetabolicphenotype
in KRAP
2/2 mice should await future studies.
In this study, we provide evidence to implicate a critical role for
KRAP in pathways regulating whole-body energy homeostasis.
Identification of the exact molecular functions of KRAP and
tissue-specific conditional knockout mouse models will lead to a
better understanding of the molecular basis for KRAP-deletion to
affect whole-body energy homeostasis. Our work identifies KRAP
as a promising new target for intervention in obesity and obesity-
related diseases and establishes the KRAP
2/2 mouse as a novel
model of metabolism-related diseases.
Figure 6. No Difference in Glucose Uptake, Differentiation or Insulin Signaling between KRAP2/2- and Wild-Type-Adipocytes in
Vitro. (A) Glucose uptake into differentiated adipocytes, from KRAP2/2 (KO)- and wild-type (WT)-BAT, measured with or without the pretreatment
of insulin. One representative data of three independent experiments performed in quadruplicate. Data are presented as mean6S.E.M.; NS, not
significant. (B) Accumulation of lipid droplets detected by Oil Red-O staining in the differentiated adipocytes. Scale bar, 100 mm. (C) Western blot
analysis of ACC and PGC-1 in the differentiated adipocytes. (D) Western blot analysis of total- and phospho-Akt (P-Akt) in the differentiated
adipocytes treated with 100 nM of insulin for the indicated period (upper) or with the indicated concentrations of insulin for 10 min (lower).
doi:10.1371/journal.pone.0004240.g006
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Animals
All the animals used in this study were treated in accordance
with the rules of Fukuoka University.
Generation of KRAP-deficient mice
We isolated a genomic DNA of the KRAP gene from a 129/SV
mouse genomic library (Stratagene) and constructed the targeting
vector by replacing a 7.2-kb XhoI-SalI fragment containing exons
11–16 (55% of the coding region) of the KRAP gene, with a
pGKneo cassette with opposite transcriptional orientation. The 59
and 39 arm of the targeting construct was composed of 2.3-kb and
6.4-kb genomic DNA, respectively. Diphtheria-toxin A fragment
cassette (DT-A) flanked the 39 genomic arm. The targeting vector
was linearized with SalI. ES cells were electroporated with the
linearized targeting vector and selected with G418 on embryonic
fibroblast feeder cells as described [33]. EcoRV digestion of
genomic DNA identified an 8.0-kb recombinant allele and a 21.0-
kb wild-type allele, when hybridized with an external probe (350-
bp XbaI fragment). The neo probe was used to confirm
homologous recombinants and ensure that there was only one
integration site. The mutant ES cells were microinjected into
C57BL6/J blastocysts as described [33], and the resulting male
chimeras were mated with C57BL6/J mice. Heterozygous offspring
were intercrossed to generate KRAP-deficient (KRAP
2/2) mice. The
KRAP
2/2 line was backcrossed six times and maintained in the
genetic background of C57BL6/J.
BW regulation
Animals were maintained in a temperature-controlled (23uC)
facility with a 12 h light/dark cycle. Mice had ad libitum access to
water and standard rodent chow. Body weights were recorded
weekly.
Organ weight study
Age-matched (20 week-old) male KRAP
2/2 (n=9) and wild-type
(n=9) mice were sacrificed and the wet weights of epididymal
WAT and interscapular BAT were measured.
Histological study
WAT, BAT, skin, liver and muscle of 22 week-old male mice
were obtained under fed condition. Tissues were fixed in 3.7%
formaldehyde in PBS, dehydrated in ethanol, embedded in
paraffin. Sections were deparaffinized, rehydrated and stained
with hematoxylin and eosin. Adipocyte perimeter from 200 cells
was determined using Image J software from images of
hematoxylin and eosin staining. Liver paraffin sections of mice
after 14 weeks feeding of high-fat diet 32 (CLEA-Japan) were
subjected to Oil Red-O staining to detect lipid droplets and
counterstained with hematoxylin.
Tissue triglyceride content
Tissue triglyceride was extracted [34], and measured with an
enzymatic triglyceride E-test Wako (Wako Co.).
Food intake study
Age-matched (30–36 week-old) male KRAP
2/2 and wild-type
(n=6) mice were given standard diet for 7 days. BWs were
recorded every 24 h. Food, previously weighed, was offered to
mice for 7 days. Every 24 h, the remaining food including crumbs




Age-matched (22 week-old) male KRAP
2/2 (n=8) and wild-type
(n=7) mice were kept for 3 days an individual metabolic cages
(48 h for the acclimation of the mice to the metabolic cages,
followed by 24 h for the measurement of the metabolic rate).
Oxygen consumption and carbon dioxide production in expired
air were measured continuously with an automatic O2-CO2
analyzer (NEC Medical System, model IH26) as described [35].
Energy expenditure per h and day was calculated.
Locomotor activity and body temperature
Twenty four-h after the acclimation of the mice to the cages,
spontaneous ambulatory activity of individually housed mice was
evaluated over a 24 h period using a Digital Acquisition System
(Bioresearch Center Co.). Consecutive photobeam brakes occur-
ring in adjacent photobeams were scored as an ambulatory
movement. Cumulative ambulatory activity counts were recorded
every one h throughout the light/dark cycles. During the study,
mice had ad libitum access to food and water. Body temperature
was assessed by measuring rectal temperature using a digital
thermometer (Shibaura Electronics Co.).
BW regulation on a high-fat diet
Age-matched (23 week-old) male KRAP
2/2 (n=6) and wild-type
(n=7) mice were given high-fat diet 32 (CLEA-Japan) for 4 weeks.
BWs were recorded every 2 days. Food, previously weighed, was
offered to mice for 4 weeks. Every 2 day periods, the remaining
food, including crumbs, was weighed and the daily food intake (g/
day/BW
0.75) was estimated. After the 4 weeks period on a high fat
diet, mice were subjected to measurements of energy metabolism
as described above.
Serum chemistry
Blood was collected from the retroorbital sinus in the fed state.
Blood was kept on ice until centrifugation (3,000 g, 15 min at 4uC),
and the serum was stored at 270uC until analysis. Serum insulin,
leptin, adiponectin, T4, IGF-1 and glucagon concentrations were
measured using ELISA kits (Shibayagi Co., R&D Systems, Otsuka
Pharmaceutical Co., Endocrinetech. Co., R&D Systems and
Yanaihara Research Co., respectively). Serum T3 and growth
hormone were measured using RIA kits (Diagnostic Products Co.
and GE Healthcare, respectively). Triglycerides, total cholesterol,
FFA and albumin were determined by enzymatic assays (Wako
Co.). Tail vein blood was used for glucose and ketone body
quantifications with the Medisense Xtra (Abbott Laboratories Co.).
Northern blotting
Northern blotting was performed as described [10]. The cDNA
fragments of Actb, Acox1, Acaca (also known as Acc1), Acacb (also
known as Acc2), Ucp1, Ucp2, Lpl, Hsl, Pparg, Leptin, Fabp4, Rplp0 and
Pgc1a were prepared by reverse transcriptase PCR using the
primers listed in Table S5.
Western blotting
Western blotting was performed as described [10]. Specific
signals were detected by using KRAP antibody [10], Actin
antibody (A2066, Sigma), phospho-ACC (Ser79) antibody (07-303,
Upstate), Fatty acid synthase antibody (clone23, BD Biosciences),
AMPK antibody (#2532, Cell Signaling), phospho-AMPK
(Thr172) antibody (#2535, Cell Signaling), PGC-1a antibody
(AB3242, Chemicon), Akt antibody (#9272, Cell Signaling) and
Phospho-Akt (Ser473) antibody (#9271, Cell Signaling). To detect
ACC proteins, avidin-HRP (GE Healthcare) was used.
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HepG2 cells were cultured at 37uC with 5% CO2 in DMEM
containing 10% fetal calf serum (FCS), and transfected with a small
inhibitory RNA (siRNA) using MicroPorator MP-100 (Digital Bio)
as described [10]. Two distinct siRNAs were designed to target the
coding region of human KRAP gene (nucleotides 1179–1203 and
1524–1548, GenBank accession no. AB116937) [10].
Intraperitoneal glucose tolerance test, insulin secretion
after glucose injection test or insulin sensitivity test
Intraperitoneal glucose tolerance test, using a dose of 2 g
glucose/kg BW, was performed on overnight fasted animals.
Insulin secretion after glucose injection test was carried out by
measuring serum insulin concentrations before and 10 min after
the single glucose i.p. injection at a dose of 2 g glucose/kg BW.
Insulin sensitivity test was done on 3 h fasted animals followed by
injection of insulin at a dose of 0.75 U/kg BW. Tail vein blood
was collected 15, 30, 60, 90 and 120 min after injection and used
for glucose quantification with the Medisense Xtra.
Whole-body
18F-FDG PET
Age-matched (7-month-old) male wild-type (n=5) and KRAP
2/2
(n=5) mice were injected into a tail vein with 1 nmol/kg BW
(150 MBq/kg BW) of 2-deoxy-2-[
18F]fluoro-D-glucose (
18F-FDG).
The emission scan was started immediately after the injection and
performed for 60 min with a planar positron imaging system as
described [36]. At 65 min after the injection, mice were sacrificed
and blood, brain, muscle, liver, kidney, pancreas, BAT, WAT and
bladder were collected for
18F-FDG determination.
Brown adipocyte cell culture
Brown adipocyte cell culture was done essentially as described
[37]. Briefly, BAT was isolated from newborn KRAP
2/2 and wild-
type mice, minced and subjected to collagenase digestion. The
digested tissue was filtered, washed and the resultant cells were
expanded in culture medium as described [37]. For differentiation,
preadipocytes were grown to confluence in culture medium
supplemented with 20 nM of insulin and 1 nM of T3 (differntia-
tion medium). Confluent cells were incubated for 24 h in the
differentiation medium further supplemented with 0.5 mM of
isobutylmethylxanthine, 0.5 mM of dexamethasone and
0.125 mM of indomethacin. Subsequently, the cells were main-
tained in the differentiation medium for 5 days until exhibiting a
fully differentiated phenotype with massive accumulation of fat
droplets. Glucose uptake assay was carried out after the cells were
starved in serum-free medium for 4 h, before 100 nM of insulin
was added for another 30 min. At the end of the stimulation
period, cells were exposed to 2-deoxy-[
3H]glucose (0.5 mCi/ml
final concentration) for 15 min. The incorporated radioactivity
was determined by liquid scintillation counting.
Expression array analysis
Total RNA was extracted from BAT or livers of three pairs of
littermates (32 week-old) fed normal chow, using Qiagen RNeasy
kit. Preparation of biotinylated antisnse cRNA, hybridization to
GeneChip Mouse Genome 430 2.0 Array (Affymetrix), washing,
scanning and data processing were performed according to the
manufacturers’ instructions and as described previously [10].
Output files were then loaded into GeneSpring v7.3 (Agilent
Technologies) with per chip normalization to the 50th percentile
and per-gene normalization to the average expression level of the
wild-type. Three pairs of comparisons of the gene expression
profile between KRAP
2/2 and the wild-type (KO#1 vs. WT#1,
KO#2 vs. WT#2 and KO#3 vs. WT#3) was performed. To
extract differentially expressed genes in KO compared with WT,
Venn diagrams with 1.5-fold change in the three pairs compar-
isons was used as the filtering method.
Statistical analysis
Data are presented as mean6S.E.M., and statistical analysis
was performed using an unpaired Student’s t-test when comparing
two groups means (Figure 1F, 1G, 1H, 2C, 3D, 3G, 4E, 5F, 6A,
S1, Table S1, S2). Data for the body weight, energy expenditure,
respiratory quotient, locomotor activity, food intake on an HFD,
insulin sensitivity, glucose tolerance and insulin secretion after
glucose injection (Figure 1D, 1E, 2A, 2B, 3A, 3B, 3C, 3H, 5A, 5B,
5C) were subjected to repeated measures two-way ANOVA
followed by post hoc Tukey-Kramer multiple comparisons tests.
Data for the cell perimeter of white adipose tissue (Figure S2) was
analyzed with Mann-Whitney U test. Differences at P,0.05 were
considered to be statistically significant.
Supporting Information
Figure S1 Body weight for KRAP2/2 (KO) and wild-type (WT)
mice. 18 week-old, Data are presented by mean6S.E.M. of n=8.
Found at: doi:10.1371/journal.pone.0004240.s001 (2.87 MB TIF)
Figure S2 Histological analysis of epididymal WAT, BAT, skin,
liver and skeletal muscle of 22 week-old male mice by hematoxylin
and eosin staining. Scale bar, 50 mm. (Right graph) The measure-
ment of cell perimeter of epididymal white adipose tissue (WAT) by
Image J software. Representative adipocyte perimeter distribution of
200 cells from two animals per group (Median, 193 mmf o rW T ;
144 mmf o rK O .P ,0.001 by Mann-Whitney U test).
Found at: doi:10.1371/journal.pone.0004240.s002 (9.56 MB TIF)
Figure S3 No difference in expression levels of UCP-1, GLUT-1
or COX-4 in brown adipose tissue between KRAP2/2 and wild-
type mice. Interscapular brown adipose tissue (BAT) was obtained
from KRAP2/2 (KO) and wild-type (WT) mice. Protein
expression levels of UCP-1, GLUT-1 and COX-4 were deter-
mined by western blotting. UCP-1 Ab, GLUT-1 Ab and COX-4
Ab were purchased from Sigma (U6382), Santa Cruz (H-43) and
Clontech (S2207), respectively.
Found at: doi:10.1371/journal.pone.0004240.s003 (1.94 MB TIF)
Figure S4 No difference in expression levels of UCP-3 or COX-
4 in skeletal muscle between KRAP2/2 and wild-type mice.
Skeletal muscle was obtained from KRAP2/2 (KO) and wild-
type (WT) mice. Protein expression levels of UCP-3 and COX-4
were determined by western blotting. UCP-3 Ab, COX-4 Ab and
Actin Ab were purchased from Sigma (U7757), Clontech (S2207)
and Sigma (A2066), respectively.
Found at: doi:10.1371/journal.pone.0004240.s004 (2.15 MB TIF)
Figure S5 Absence of significant activations of Akt or Insulin
receptor b in the KRAP2/2-BAT in fasted condition. Interscap-
ular brown adipose tissue (BAT) was obtained from KRAP2/2
(KO) and wild-type (WT) mice. (A) Protein expression levels of
Akt, phospho-Akt (Ser473) (P-Akt) and Actin were determined by
western blotting. As a positive control for P-Akt, lysate from
cultured adipocytes treated with 100 nM of insulin for 5 min was
used. Akt Ab, phospho-Akt (Ser473) Ab and Actin Ab were
purchased from Cell Signaling (#9272), Cell Signaling (#9271)
and Sigma (A2066), respectively. (B) Protein expression levels of
total- and phospho-Insulin receptor (IR) b (Tyr972) were
determined by western blotting. Immunoprecipitates with IRb
Ab were immunoblotted by IRb Ab (C-19, Santa Cruz) or
phospho-IRb (Tyr972) Ab (44-800G, BIOSOURCE).
KRAP in Energy Homeostasis
PLoS ONE | www.plosone.org 9 January 2009 | Volume 4 | Issue 1 | e4240Found at: doi:10.1371/journal.pone.0004240.s005 (4.85 MB TIF)
Figure S6 Upper Venn diagrams showed the up-regulated 114
probesets and down-regulated 158 probesets in KRAP2/2-brown
adipose tissue. Lower Venn diagrams showed the up-regulated 119
probesets and down-regulated 223 probesets in KRAP2/2-liver. A
cut-off value of 1.5-fold or more change between the KRAP2/2
(KO) and the wild-type (WT) tissues was used. The data of the
differentially expressed genes were provided in Table S3 and S4.
Found at: doi:10.1371/journal.pone.0004240.s006 (10.08 MB
TIF)
Table S1 Metabolic profiles of KRAP2/2 and wild-type mice in
the C57BL6/J genetic background. Body weights of KRAP2/2
and wild-type mice were measured at birth. For liver glycogen
measurement, livers from 20 week-old male mice under standard
diet were homogenized in 3% (w/w) perchloric acid and the
homogenate was incubated for 2 h at 40uC with amyloglucosidase
to hydrolyze the glycogen. The resulting glucose residue was then
measured using an enzymatic glucose test Wako. The content of
undigested proteins in fecal samples was examined using a Bradford
ULTRA (novexin) with water-homogenized fecal samples. Oxygen
consumption and carbon dioxide production in expired air were
measured continuously with an automatic O2-CO2 analyzer (NEC
Medical System, model IH26) and the respiratory quotient was
calculated. Respiratory quotient of mice after 4 weeks of high-fat
diet were also examined. Triglyceride content in liver and muscle
from mice fed a high-fat diet for 14 weeks was measured with
triglyceride E-test Wako (Wako Co.). Serum glucose was measured
after 10 weeks of high-fat diet with the Medisense Xtra (Abbott
Laboratories Co.). Serum insulin, leptin and adiponectin were
measured after 10 weeks of high-fat diet with ELISA kits (Shibayagi
Co., R&D Systems and Otsuka Pharmaceutical Co., respectively).
n, number; Data are presented by mean6S.E.M.
Found at: doi:10.1371/journal.pone.0004240.s007 (0.04 MB
DOC)
Table S2 Serum chemistry of wild-type and KRAP2/2 mice.
All samples were from mice on a standard diet and assessed for
serum parameters as described in Methods. Data are presented as
the mean6S.E.M.; *P,0.05 and P,0.01 compared with wild-
type controls. n, number; FFA, free fatty acid; T3, triiodothyro-
nine; T4, thyroxine.
Found at: doi:10.1371/journal.pone.0004240.s008 (0.05 MB
DOC)
Table S3 Gene Ontology (GO) terms enriched in the down-
regulated genes in KRAP2/2-BAT. Out of 158 down-regulated
genes, 104 genes were found to have GO term annotations and
subjected to GO term enrichment analysis. Expression data for
1.5-fold or more down- and up-regulated genes in KRAP2/2-
BAT. Microarray gene expression analysis was performed on the
brown adipose tissues from three pairs of KRAP2/2 (KO) and
the wild-type (WT) controls.
Found at: doi:10.1371/journal.pone.0004240.s009 (0.64 MB
DOC)
Table S4 Gene Ontology (GO) terms enriched in the down-
regulated genes in KRAP2/2-liver. Out of 223 down-regulated
genes, 151 genes were found to have GO term annotations and
subjected to GO term enrichment analysis. Expression data for 1.5-
fold or more down- and up-regulated genes in KRAP2/2-liver.
Microarray gene expression analysis was performed on the livers
from three pairs of KRAP2/2 (KO) and the wild-type (WT)
controls.
Found at: doi:10.1371/journal.pone.0004240.s010 (0.95 MB
DOC)
Table S5 Primer sequences for preparation of probes used in
northern blotting.
Found at: doi:10.1371/journal.pone.0004240.s011 (0.03 MB
DOC)
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